We establish that genetic ablation of Cbx3/HP1γ induces the elevated, sustained expression of factors conferring both persistence and heightened effector/killing capacity on CD8+ T cells, which in turn enables them to control the growth of diverse tumor types. This evidence concerns the gene CD8A and neoplasm.